Literature DB >> 20198430

Naturally occurring glycoalkaloids in potatoes aggravate intestinal inflammation in two mouse models of inflammatory bowel disease.

Vadim Iablokov1, Beate C Sydora, Rae Foshaug, Jon Meddings, Darcy Driedger, Tom Churchill, Richard N Fedorak.   

Abstract

BACKGROUND: Inflammatory bowel disease (IBD) may be initiated following disruption of the intestinal epithelial barrier. This disruption, in turn, permits luminal antigens unfettered access to the mucosal immune system and leads to an uncontrolled inflammatory response. Glycoalkaloids, which are found in potatoes, disrupt cholesterol-containing membranes such as those of the intestinal epithelium. Glycoalkaloid ingestion through potatoes may play a role in the initiation and/or perpetuation of IBD. AIM: To determine if commercial and high glycoalkaloids containing fried potato skins aggravate intestinal inflammation using two different animal models of IBD.
METHODS: Fried potato skins from commercial potatoes containing low/medium glycoalkaloid levels and high glycoalkaloids potatoes were fed for 20 days to interleukin 10 gene-deficient mice and dextran sodium sulfate-induced colitic mice. Intestinal permeability, mucosal cytokine and myeloperoxidase levels and body weight were determined to assess intestinal injury.
RESULTS: Deep frying potato skins markedly increased glycoalkaloid content. Interleukin 10 gene-deficient mice fed fried commercial potato skins with medium glycoalkaloid content exhibited significantly elevated levels of ileal IFN-γ relative to controls. Mice in the dextran sodium sulfate colitis model that were fed the same strain of potatoes demonstrated significantly elevated levels of pro-inflammatory cytokines IFN-γ, TNF-α, and IL-17 in the colon in addition to an enhanced colonic permeability. Inflammatory response was intensified when the mice were fed potatoes with higher glycoalkaloid contents.
CONCLUSIONS: Our results demonstrate that consumption of potato skins containing glycoalkaloids can significantly aggravate intestinal inflammation in predisposed individuals.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20198430     DOI: 10.1007/s10620-010-1158-9

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  19 in total

1.  Rapid development of colitis in NSAID-treated IL-10-deficient mice.

Authors:  Daniel J Berg; Juan Zhang; Joel V Weinstock; Hanan F Ismail; Keith A Earle; Hector Alila; Rifat Pamukcu; Steven Moore; Richard G Lynch
Journal:  Gastroenterology       Date:  2002-11       Impact factor: 22.682

2.  Potato glycoalkaloids adversely affect intestinal permeability and aggravate inflammatory bowel disease.

Authors:  Bijal Patel; Robert Schutte; Peter Sporns; Jason Doyle; Lawrence Jewel; Richard N Fedorak
Journal:  Inflamm Bowel Dis       Date:  2002-09       Impact factor: 5.325

Review 3.  The fundamental basis of inflammatory bowel disease.

Authors:  Warren Strober; Ivan Fuss; Peter Mannon
Journal:  J Clin Invest       Date:  2007-03       Impact factor: 14.808

Review 4.  Potato glycoalkaloids and metabolites: roles in the plant and in the diet.

Authors:  Mendel Friedman
Journal:  J Agric Food Chem       Date:  2006-11-15       Impact factor: 5.279

5.  Membrane disruption and enzyme inhibition by naturally-occurring and modified chacotriose-containing Solanum steroidal glycoalkaloids.

Authors:  J G Roddick; M Weissenberg; A L Leonard
Journal:  Phytochemistry       Date:  2001-03       Impact factor: 4.072

6.  Potato glycoalkaloids and adverse effects in humans: an ascending dose study.

Authors:  Tjeert T Mensinga; Adrienne J A M Sips; Cathy J M Rompelberg; Klaas van Twillert; Jan Meulenbelt; Hester J van den Top; Hans P van Egmond
Journal:  Regul Toxicol Pharmacol       Date:  2004-12-10       Impact factor: 3.271

7.  Interleukin-10-deficient mice develop chronic enterocolitis.

Authors:  R Kühn; J Löhler; D Rennick; K Rajewsky; W Müller
Journal:  Cell       Date:  1993-10-22       Impact factor: 41.582

8.  Distribution of glycoalkaloids in potato tubers of 59 accessions of two wild and five cultivated Solanum species.

Authors:  Nobuyuki Kozukue; Kyung-Soon Yoon; Gwang-In Byun; Shuji Misoo; Carol E Levin; Mendel Friedman
Journal:  J Agric Food Chem       Date:  2008-12-24       Impact factor: 5.279

9.  Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines.

Authors:  L A Dieleman; M J Palmen; H Akol; E Bloemena; A S Peña; S G Meuwissen; E P Van Rees
Journal:  Clin Exp Immunol       Date:  1998-12       Impact factor: 4.330

10.  Molecular basis of glycoalkaloid induced membrane disruption.

Authors:  E A Keukens; T de Vrije; C van den Boom; P de Waard; H H Plasman; F Thiel; V Chupin; W M Jongen; B de Kruijff
Journal:  Biochim Biophys Acta       Date:  1995-12-13
View more
  9 in total

1.  α-Chaconine Facilitates Chondrocyte Pyroptosis and Nerve Ingrowth to Aggravate Osteoarthritis Progression by Activating NF-κB Signaling.

Authors:  Zhiguo Zhang; Fangda Fu; Yishan Bian; Huihao Zhang; Sai Yao; Chengcong Zhou; Yuying Ge; Huan Luo; Yuying Chen; Weifeng Ji; Kun Tian; Ming Yue; Weibin Du; Hongting Jin; Peijian Tong; Chengliang Wu; Hongfeng Ruan
Journal:  J Inflamm Res       Date:  2022-10-17

Review 2.  Microbiome-Epigenome Interactions and the Environmental Origins of Inflammatory Bowel Diseases.

Authors:  Tatiana Y Fofanova; Joseph F Petrosino; Richard Kellermayer
Journal:  J Pediatr Gastroenterol Nutr       Date:  2016-02       Impact factor: 2.839

Review 3.  Recent Trends in Pharmacological Activity of Alkaloids in Animal Colitis: Potential Use for Inflammatory Bowel Disease.

Authors:  Ana Cristina Alves de Almeida; Felipe Meira de-Faria; Ricardo José Dunder; Luis Paulo Bognoni Manzo; Alba Regina Monteiro Souza-Brito; Anderson Luiz-Ferreira
Journal:  Evid Based Complement Alternat Med       Date:  2017-01-09       Impact factor: 2.629

Review 4.  Bioactivity of Polyphenols: Preventive and Adjuvant Strategies toward Reducing Inflammatory Bowel Diseases-Promises, Perspectives, and Pitfalls.

Authors:  Anouk Kaulmann; Torsten Bohn
Journal:  Oxid Med Cell Longev       Date:  2016-07-10       Impact factor: 6.543

5.  Design of an anti-inflammatory diet (ITIS diet) for patients with rheumatoid arthritis.

Authors:  Marta F Bustamante; Meritxall Agustín-Perez; Francesca Cedola; Roxana Coras; Rekha Narasimhan; Shahrokh Golshan; Monica Guma
Journal:  Contemp Clin Trials Commun       Date:  2020-01-21

6.  α-Chaconine Affects the Apoptosis, Mechanical Barrier Function, and Antioxidant Ability of Mouse Small Intestinal Epithelial Cells.

Authors:  Yuhua He; Jiaqi Chen; Qiyue Zhang; Jialong Zhang; Lulai Wang; Xiaoxia Chen; Adrian J Molenaar; Xuezhao Sun
Journal:  Front Plant Sci       Date:  2021-06-09       Impact factor: 5.753

7.  A Pilot Low-Inflammatory Dietary Intervention to Reduce Inflammation and Improve Quality of Life in Patients With Familial Adenomatous Polyposis: Protocol Description and Preliminary Results.

Authors:  Patrizia Pasanisi; Manuela Gariboldi; Paolo Verderio; Stefano Signoroni; Andrea Mancini; Licia Rivoltini; Massimo Milione; Enzo Masci; Chiara Maura Ciniselli; Eleonora Bruno; Alessandra Macciotta; Antonino Belfiore; Maria Teresa Ricci; Giuliana Gargano; Daniele Morelli; Giovanni Apolone; Marco Vitellaro
Journal:  Integr Cancer Ther       Date:  2019 Jan-Dec       Impact factor: 3.279

8.  Habitual dietary intake of IBD patients differs from population controls: a case-control study.

Authors:  Gerard Dijkstra; Marjo J E Campmans-Kuijpers; Vera Peters; Ettje F Tigchelaar-Feenstra; Floris Imhann; Jackie A M Dekens; Morris A Swertz; Lude H Franke; Cisca Wijmenga; Rinse K Weersma; Behrooz Z Alizadeh
Journal:  Eur J Nutr       Date:  2020-04-24       Impact factor: 5.614

Review 9.  Food and Food Groups in Inflammatory Bowel Disease (IBD): The Design of the Groningen Anti-Inflammatory Diet (GrAID).

Authors:  Marjo J E Campmans-Kuijpers; Gerard Dijkstra
Journal:  Nutrients       Date:  2021-03-25       Impact factor: 5.717

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.